Results 111 to 120 of about 51,319 (173)

Annelation of the 1,2,4-Triazine Core to 2,3-Benzodiazepine

open access: yesЖурнал органічної та фармацевтичної хімії
A one-pot, stepwise method for the annelation of the 1,2,4-triazine core to the seven-membered 2,3-benzodiazepine ring via the interaction of the corresponding 2,3-benzodiazepin-1-yl- or 2,3-benzodiazepin-4-ylhydrazines with α-ketoesters has been ...
Natalia M. Bohdan   +4 more
doaj   +1 more source

Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as an Important Scaffold for Anticancer Drug Discovery-In Vitro and In Silico Evaluation. [PDF]

open access: yesInt J Mol Sci, 2023
Kciuk M   +9 more
europepmc   +1 more source

Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists. [PDF]

open access: yesJ Med Chem, 2022
Mahindra A   +12 more
europepmc   +1 more source

Genotoxicity of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides in Normal and Cancer Cells In Vitro. [PDF]

open access: yesInt J Mol Sci, 2023
Kciuk M   +6 more
europepmc   +1 more source

Synthesis and antifungal activity of 4-substituted-3, 7 –dimethylpyrazolo [3,4-e] [1,2,4] triazine

open access: yes, 2002
664-667A convenient synthesis and antifungal activity of four compounds namely 2-(3, 7-dimethyl-4H-pyrazolo[3,4-e][1,2,4]triazin-4-yl)acetic acid 2, 3,7-dimethyl-4-(4-methylphenyl-pyrazolo[3,4-e][1,2,4]triazine 3, 4-(3,7-dimethyl-4H-pyrazolo[3,4-e][1 ...
Tewari, Ashish Kumar   +3 more
core  

Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma. [PDF]

open access: yesInt J Mol Sci, 2023
Carbone D   +11 more
europepmc   +1 more source

Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma. [PDF]

open access: yesMar Drugs, 2023
Carbone D   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy